Article

Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments

Received:

Accepted:

Published online:

Citation:European Cardiology Review 2019;14(3):201

Open access:

This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.

In the article by Juan Tamargo entitled Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments (European Cardiology Review 2019;14(1):23–32. https://doi.org/10.15420/ecr.2018.34.2), the following correction should be made:

Figure 1 should indicate an increase () in haemoglobin and haematocrit, not a decrease (). The corrected figure appears below.

The author apologises for this error.

Potential Mechanisms Involved in the Cardioprotective and Renoprotective Effects

Article image